UNICA IRIS Institutional Research Information System

FRAU, JESSICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 277.027
NA - Nord America 13.545
AS - Asia 5.812
SA - Sud America 883
Continente sconosciuto - Info sul continente non disponibili 724
AF - Africa 141
OC - Oceania 11
Totale 298.143
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 273.970
US - Stati Uniti d'America 13.311
SG - Singapore 2.280
CN - Cina 2.001
BR - Brasile 674
SE - Svezia 614
UA - Ucraina 587
VN - Vietnam 506
DE - Germania 469
FI - Finlandia 350
FR - Francia 304
GB - Regno Unito 300
HK - Hong Kong 189
BD - Bangladesh 159
IN - India 145
CA - Canada 122
NL - Olanda 99
KR - Corea 98
AR - Argentina 74
IQ - Iraq 55
MX - Messico 55
RU - Federazione Russa 47
ZA - Sudafrica 46
AT - Austria 45
TR - Turchia 45
ES - Italia 42
PK - Pakistan 36
PL - Polonia 35
MA - Marocco 33
JP - Giappone 31
CZ - Repubblica Ceca 30
PH - Filippine 28
CO - Colombia 26
ID - Indonesia 26
UZ - Uzbekistan 25
EC - Ecuador 24
VE - Venezuela 24
SA - Arabia Saudita 23
BE - Belgio 21
CL - Cile 21
MY - Malesia 21
EU - Europa 17
IL - Israele 16
IE - Irlanda 14
JO - Giordania 14
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
IR - Iran 12
LT - Lituania 12
KE - Kenya 11
TN - Tunisia 11
AU - Australia 10
CR - Costa Rica 10
DZ - Algeria 10
GR - Grecia 10
JM - Giamaica 10
NP - Nepal 10
OM - Oman 10
PS - Palestinian Territory 10
EG - Egitto 9
HU - Ungheria 9
PE - Perù 9
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
KZ - Kazakistan 8
PY - Paraguay 8
RS - Serbia 8
TH - Thailandia 8
HR - Croazia 7
BO - Bolivia 6
LB - Libano 6
MD - Moldavia 6
TW - Taiwan 6
AL - Albania 5
BG - Bulgaria 5
CH - Svizzera 5
DK - Danimarca 5
GT - Guatemala 5
RO - Romania 5
SN - Senegal 5
EE - Estonia 4
ET - Etiopia 4
KW - Kuwait 4
PR - Porto Rico 4
SV - El Salvador 4
BB - Barbados 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
CY - Cipro 3
GY - Guiana 3
LA - Repubblica Popolare Democratica del Laos 3
NO - Norvegia 3
PA - Panama 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
BH - Bahrain 2
GD - Grenada 2
KG - Kirghizistan 2
KH - Cambogia 2
MM - Myanmar 2
Totale 297.404
Salva come PNG Salva come JPEG
Città #
Cagliari 267.371
Uta 5.480
Ashburn 1.316
Singapore 1.140
Fairfield 1.055
Woodbridge 785
San Jose 703
Dallas 626
Chandler 579
Houston 521
Boardman 504
Wilmington 471
Seattle 408
Beijing 404
Cambridge 383
Ann Arbor 365
Nyköping 349
Los Angeles 344
Council Bluffs 298
Chicago 294
Jacksonville 276
Helsinki 236
New York 212
Santa Clara 190
Dearborn 187
Hong Kong 166
Lauterbourg 162
The Dalles 158
Nanjing 153
Ho Chi Minh City 147
Buffalo 143
Shanghai 142
Munich 140
Hefei 137
Salt Lake City 131
Boston 121
Milan 112
Hanoi 97
Seoul 96
Rome 77
Elk Grove Village 68
Tampa 67
San Diego 65
São Paulo 64
Columbus 62
Norwalk 60
Atlanta 58
Orem 57
Shenyang 55
Guangzhou 54
Toronto 53
Phoenix 49
Nanchang 47
Dong Ket 46
Redwood City 46
Washington 44
Brooklyn 43
London 43
Jiaxing 40
Redondo Beach 40
Hebei 37
Sterling 35
Verona 34
Frankfurt am Main 32
Miami 32
Sassari 32
Tianjin 31
Vienna 28
Warsaw 28
Amsterdam 27
Da Nang 27
Denver 27
Mexico City 27
Detroit 26
Hangzhou 26
Lancaster 26
Nuremberg 26
Changsha 25
Montreal 25
Düsseldorf 24
Tokyo 24
Johannesburg 23
Stockholm 23
Chennai 22
Domusnovas 20
Tashkent 20
Turku 20
Xi'an 20
Baghdad 19
Mountain View 19
San Francisco 19
Shenzhen 19
Zhengzhou 19
Florence 18
Jinan 17
Naples 17
Brussels 16
Casablanca 16
Dulles 16
Taizhou 15
Totale 288.497
Salva come PNG Salva come JPEG
Nome #
Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation 6.165
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.994
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.947
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.590
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.497
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.314
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.225
Overexpression of the cytokine BAFF and autoimmunity risk 4.141
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 4.056
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 4.026
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia 3.992
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.943
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.903
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.846
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.832
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.736
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.672
Walking improvements with nabiximols in patients with multiple sclerosis 3.655
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.624
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.618
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.602
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.594
A genetic association study of two genes linked to neurodegeneration in a Sardinian multiple sclerosis population: The TARDBP Ala382Thr mutation and C9orf72 expansion 3.520
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.446
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.414
Impact of the media on future hope in multiple sclerosis 3.394
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.325
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.319
Combining HLA-DRB1-DQB1 and Mycobacterium Avium Subspecies Paratubercolosis (MAP) antibodies in Sardinian multiple sclerosis patients: associated or independent risk factors? 3.298
Oral agents in multiple sclerosis 3.217
Influence of treatments in multiple sclerosis disability: a cohort study 3.193
‘Timed up and go’ and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis 3.170
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.124
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 3.065
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 3.054
Refining the connection between gait and cognition: training the body to improve the brain 2.990
Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis 2.988
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.982
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.888
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.880
Postural adaptation during a Nintendo Wii balance training 2.676
Pregnancy planning and outcomes in patients with multiple sclerosis after mitoxantrone therapy: A monocentre assessment 2.649
Assessing the Metabolomic Profile of Multiple Sclerosis Patients Treated with Interferon Beta 1a by 1 H-NMR Spectroscopy 2.632
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.564
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 2.543
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.457
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patient 2.414
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.344
The cohort of the multiple sclerosis center of Cagliari 2.340
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.336
Balance patterns in people with multiple sclerosis using Nintendo Wii 2.323
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.295
Induction and escalation therapies in multiple sclerosis 2.291
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.261
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 2.250
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.242
Entropy of human leukocyte antigen and killer-cell immunoglobulin-like receptor systems in immune-mediated disorders: A pilot study on multiple sclerosis 2.230
Rituximab in the treatment of Neuromyelitis optica: a multicentre Italian observational study 2.120
Does focal inflammation have an impact on cognition in multiple sclerosis? An MRI study 2.107
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.075
Tardbp ala382thr mutation in multiple sclerosis: A possible role in brain atrophy 2.068
Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis 1.995
Clinical activity after fingolimod cessation: disease reactivation or rebound? 1.980
Epidemiology of multiple sclerosis in south-western Sardinia 1.941
The impact of deep grey matter volume on cognition in Multiple Sclerosis 1.821
Coenzyme Q10 in the cerebrospinal fluid of multiple sclerosis patients 1.812
Evaluation of FMR1 gene premutation in Sardinians multiple sclerosis 1.759
Anti Mycobacterium avium subsp. paratuberculosis heat shock protein 70 antibodies in the sera of Sardinian patients with multiple sclerosis 1.727
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 1.710
Occurence of autoimmune diseases in Sardinian multiple sclerosis patients and in their first degree relatives 1.653
Characterization of gait abnormalities in individuals affected by multiple sclerosis by means of the Gait Profile Score 1.650
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 1.622
EBNA-1 IgG titers in Sardinian multiple sclerosis patients and controls 1.613
Soluble BAFF Level Is Not Correlated to Mycobacterium avium Subspecies Paratuberculosis Antibodies and Increases After Interferon-β Therapy in Multiple Sclerosis Patients 1.608
Association of Mycobacterium avium subsp. paratuberculosis and SLC11A1 polymorphisms in Sardinian multiple sclerosis patients 1.576
Association of Mycobacterium avium subsp paratuberculosis with Multiple Sclerosis in Sardinian Patients 1.574
Human interferon regulatory factor 5 homologous epitopes of Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis induce a specific humoral and cellular immune response in multiple sclerosis patients 1.563
Timed Up and Go in men and women with Multiple Sclerosis: effect of muscular strength 1.561
Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients 1.507
Monoclonal antibodies: a target therapy for multiple sclerosis 1.499
Relationship between HLA DRB1-DQB1 haplotypes and oligoclonal IgG bands in Sardinians MS patients 1.411
Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). 1.400
Change in upper limb function in people with multiple sclerosis treated with nabiximols: a quantitative kinematic pilot study 1.390
Autoimmune diseases in Sardinian multiple sclerosis patients and in their first degree relatives 1.362
Assessing the burden of vascular risk factors on brain atrophy in multiple sclerosis: A case- control MRI study 1.347
Outcomes after fingolimod to alemtuzumab treatment shift in relapsing–remitting MS patients: a multicentre cohort study 1.346
Progressive multiple sclerosis and mood disorders 1.323
Delayed effect of age at onset on disability progression in multiple sclerosis 1.313
Factors interfering with parenthood decision-making in an Italian sample of people with multiple sclerosis: an exploratory online survey 1.302
The impact of visible and invisible symptoms on employment status, work and social functioning in Multiple Sclerosis 1.297
Does Multiple Sclerosis Differently Impact Physical Activity in Women and Man? A Quantitative Study Based on Wearable Accelerometers 1.297
Post-natalizumab clinical and radiological findings in a cohort of multiple sclerosis patients: 12-month follow-up 1.268
PML in a person with multiple sclerosis: Is teriflunomide the felon? 1.238
Are Mycobacterium avium subsp. paratuberculosis and Epstein-Barr virus triggers of multiple sclerosis in Sardinia? 1.229
Efficacy and safety of alemtuzumab in a real-life cohort of patients with multiple sclerosis 1.217
The burden of multiple sclerosis and patients' coping strategies 1.188
Effect of different dosages of interferon beta-1a in relapsing remitting MS patients 1.160
Coenzyme Q10 in the CSF of MS patients 1.145
Q10 in the CSF of MS patients 1.136
Gait initiation evaluation in multiple sclerosis 1.118
Totale 256.114
Salva come PNG Salva come JPEG
Categoria #
all - tutte 369.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 369.506
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211.008 0 811 509 1.140 1.076 743 514 626 1.361 1.315 1.601 1.312
2022/202317.134 1.459 2.510 2.363 1.485 1.472 1.711 777 1.379 980 979 1.288 731
2023/202418.811 1.099 962 833 1.260 1.750 3.239 2.200 1.879 949 1.296 1.700 1.644
2024/202561.458 20.721 19.853 6.452 3.738 2.015 2.220 3.213 213 604 567 1.278 584
2025/202613.102 885 583 1.185 1.151 937 897 2.479 1.198 742 1.200 893 952
2026/20271.038 543 495 0 0 0 0 0 0 0 0 0 0
Totale 298.143